David Faleck is a Gastroenterology physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 160 publications with 2,431 citations (h-index 27); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
160 E 53rd St Fl 5
New York, NY 10022
Telephone
212-639-3904Registry record last updated 18 Dec 2018.
Clinical trials
- A Study of SER-155 to Treat Diarrhea in People on Immunotherapy
Sponsor: Memorial Sloan Kettering Cancer Center
- Stool Transplant to Control Treatment-related Diarrhea
Sponsor: Memorial Sloan Kettering Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20252 payments
- Gilead Sciences, Inc.Program year20242 payments
- Janssen Research & Development, LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
77.9%Aminosalicylate33.1%Mesalamine85%Mesalamine Er15%Part D<11 patientsProton pump inhibitor25.2%Omeprazole64%Esomeprazole Magnesium18%Pantoprazole Sodium18%Part D<11 patients+ 4 more classes in this area
Respiratory
10.7%Corticosteroid10.7%Budesonide Dr64%Budesonide Ec36%Part D≥17 patientsCancer & immunology
8.8%JAK inhibitor5%Rinvoq100%Part D<11 patientsInterleukin-23 Antagonist3.8%Skyrizi On-Body100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Nature Communications
2024 - Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients
Gastrointestinal Endoscopy
2024 - Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr: SAPPHIRE Registry
Clinical Gastroenterology and Hepatology
2024 - Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis
The Journal of Experimental Medicine
2024 - Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors
Journal for ImmunoTherapy of Cancer
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Valerie Rusch, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”